Could I be wrong? Exploring cognitive bias, curiosity, intellectual humility, and lifelong learning

By SharpBrains | November 30, 2021

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing eight time­ly sci­en­tif­ic and indus­try news plus a few fun teasers to appre­ci­ate our unique human brains. #1. Could I be wrong? Explor­ing research on cog­ni­tive bias, curios­i­ty, intel­lec­tu­al humil­i­ty, and life­long learn­ing “None of us thinks that our beliefs and atti­tudes are incor­rect; if we…

Read More

FDA-approved, Cybin-sponsored clinicial trial to measure ketamine’s impact on the brain via Kernel Flow neuroimaging helmet

By SharpBrains | November 22, 2021

Kernel’s Brain-Imag­ing Hel­met Approved For Clin­i­cal Tri­al On Patients Using Ket­a­mine (Forbes): The U.S. Food and Drug Admin­is­tra­tion has approved a clin­i­cal tri­al using a neu­roimag­ing hel­met made by Los Ange­les-based Ker­nel to track what hap­pens in the brain when a human takes a psy­che­del­ic dose of ketamine.

Read More

Neuroimaging, big data and mental health: A survey of the land

By SharpBrains | January 15, 2021

Men­tal and degen­er­a­tive dis­or­ders are among the most cost­ly and com­mon caus­es of dis­abil­i­ty in soci­ety today. Because the brain is the most com­plex organ in the human body, diag­nos­ing and treat­ing prob­lems when things go wrong pos­es enor­mous chal­lenges. Even before the 1990s was des­ig­nat­ed the Decade of the Brain, the poten­tial of neuroimaging—the…

Read More

Update: The placebo effect works even when people know they are taking a placebo

By Alvaro Fernandez | August 27, 2020

Wel­come to a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing 14 research find­ings, resources and tips for brain health … and start­ing with this fas­ci­nat­ing study: #1. Wow. The place­bo effect works even when peo­ple know they are tak­ing a place­bo #2. Beat­ing Alzheimer’s Dis­ease will require a com­bined physical/ men­tal approach: From the ten fac­tors found…

Read More